Experiment 595946
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | GOSS,G: MULDAL,A: LOHMANN,R: TAYLOR,M: LOPEZ,P: ARMITAGE,G: STEWARD,WP:. (1995). DIDEMNIN B IN FAVORABLE HISTOLOGY NON-HODGKIN'S LYMPHOMA: A PHASE II STUDY OF THE NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP.. 13(3) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE II TRIAL OF EFFICACY IN TREATING NON-HODGKIN'S LYMPHOMA - STAGE III/IV, LOW GRADE. NO RESPONSE WAS SEEN. SIDE-EFFECTS INCLUDED HYPERSENSITIVITY, NAUSEA, VOMITING, FATIGUE, DIARRHEA AND RASH. |
| Dose amount | 2.3 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |